the "who's" of genomic markers: who to biopsy
Published 7 years ago • 133 plays • Length 17:33Download video MP4
Download video MP3
Similar videos
-
14:50
the "who's" of genomic markers: who to re biopsy
-
12:53
the "who's" of genomic markers: who to treat
-
33:52
the use of genomic markers and prostate biopsy decisions
-
12:30
the pros and cons of genomic markers for biopsy guidance
-
12:05
genomic markers and dna sequencing testing
-
26:20
mapping pathology as a guide to focal therapy the role of mapping biopsies and tissue markers
-
11:03
biomarkers for prostate cancer: whom to treat
-
1:31:20
psl 75 - gene, genome, genomics - the 3gs and the society
-
11:39
urologic debate part 2: mri vs. molecular markers: which one should i use? markers perspective
-
2:17
genomic markers in prostate cancer
-
8:53
pro: the role of currently available biomarkers genomics in risk stratification of prostate cancer
-
13:24
genetics and genomic biomarkers: how molecular markers and mpmri play a role
-
16:56
improving specificity of psa screening w/ serum & urine markers: who doesn’t need a prostate biopsy?
-
17:40
when to biopsy: the role for psa and novel biomarkers
-
13:25
progess in understanding pathology of prostate cancer
-
7:14
genetic testing for bladder cancer - urology care foundation
-
20:50
active surveillance 2021 - from bench to bedside
-
10:13
the role of genetic testing in prostate cancer
-
29:23
how should we monitor patients during surveillance?